Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04672434 |
| Title | Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Symphogen A/S |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| START Midwest | Grand Rapids | Michigan | 49545 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| NEXT Oncology | San Antonio | Texas | 78229 | United States | Details | |
| Princess Margaret Cancer Centre | Toronto | Ontario | M5G 1Z5 | Canada | Details |